As of 2025-05-12, the Fair Value of Revance Therapeutics Inc (RVNC) is -8.83 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.65 USD, the upside of Revance Therapeutics Inc is -342.03%.
With the market price of 3.65 USD and our fair value calculation, Revance Therapeutics Inc (RVNC) is not a good investment. Investing in RVNC stocks now will result in a potential loss of 342.03%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -159.40 | -282.10 | -281.30 | -356.40 | -323.99 | -280.64 |
| YoY growth | -11.78% | -76.98% | 0.28% | -26.70% | 9.09% | -21.22% |
| Market Cap (mil) | 381.02 |
| P/E | |
| Forward P/E |
| EPS | -1.77 |
| Avg earnings growth rate | -21.22% |
| TTM earnings | -184.44 |